#Antiverse #AI #AIantibodyplatform #biotech #drugdiscoveryprogrammes #antibodybasedtherapeutics #antibodies #drugtargets #Gproteincoupledreceptors #GPCR #ionchannels #NxeraPharma #GPCRs #cellularcommunication #transmembraneprotein #Tcellreceptor #TCR #antiPD1antibodies #drugdiscovery
zurl.co/cAKcg
zurl.co/cAKcg
Welsh firm Antiverse raises funds for AI antibody platform
Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.
pharmaphorum.com
March 9, 2026 at 3:43 PM
In a new article published in FEBS Letters, Pei Tong et al. describe the use of an amphipol-stabilized multi-pass #transmembraneprotein as an immunogen to generate high-affinity #antibodies against #VMAT2.
Online here ➡️ doi.org/10.1002/1873...
Online here ➡️ doi.org/10.1002/1873...
August 11, 2025 at 8:00 AM
In a new article published in FEBS Letters, Pei Tong et al. describe the use of an amphipol-stabilized multi-pass #transmembraneprotein as an immunogen to generate high-affinity #antibodies against #VMAT2.
Online here ➡️ doi.org/10.1002/1873...
Online here ➡️ doi.org/10.1002/1873...